Detalhe da pesquisa
1.
Management of vaccinations in patients with non-Hodgkin lymphoma.
Br J Haematol
; 204(5): 1617-1634, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38532527
2.
The classic prognostic factors in advanced Hodgkin's lymphoma patients are losing their meaning at the time of Pet-guided treatments.
Ann Hematol
; 99(2): 277-282, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31872362
3.
Outcome of transformed follicular lymphoma worsens according to the timing of transformation and to the number of previous therapies. A retrospective multicenter study on behalf of Fondazione Italiana Linfomi (FIL).
Br J Haematol
; 185(4): 713-717, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30793297
4.
Correction to: The classic prognostic factors in advanced Hodgkin's lymphoma patients are losing their meaning at the time of pet-guided treatments.
Ann Hematol
; 100(1): 303-304, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33219839
5.
Current Treatment Options and the Role of Functional Status Assessment in Classical Hodgkin Lymphoma in Older Adults: A Review.
Cancers (Basel)
; 15(5)2023 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36900306
6.
Comparison of first-line treatment with bendamustine plus rituximab versus R-CHOP for patients with follicular lymphoma grade 3A: Results of a retrospective study from the Fondazione Italiana Linfomi.
Front Oncol
; 13: 1120967, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36969038
7.
Role of Rituximab Addition to First-line Chemotherapy Regimens in Nodular Lymphocyte-predominant Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi.
Hemasphere
; 7(4): e837, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37034003
8.
RE-MIND: Comparing Tafasitamab + Lenalidomide (L-MIND) with a Real-world Lenalidomide Monotherapy Cohort in Relapsed or Refractory Diffuse Large B-cell Lymphoma.
Clin Cancer Res
; 27(22): 6124-6134, 2021 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34433649
9.
Impact of treatment-related liver toxicity on the outcome of HCV-positive non-Hodgkin's lymphomas.
Am J Hematol
; 85(1): 46-50, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19957347
10.
Safety and efficacy of netupitant/palonosetron and dexamethasone in classical Hodgkin's lymphoma patients with inadequate chemotherapy-induced nausea and vomiting prophylaxis with palonosetron and dexamethasone: a single-center real-life experience.
Int J Hematol Oncol
; 9(1): IJH23, 2020 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-32382409